ConductScience.org, home

Paper16632342

Brain cancer stem-like cells.

Kondo T. Eur J Cancer, 2006. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Brain cancer stem-like cells. Papers, record 16632342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16632342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Brain cancer stem-like cells.
PubMed
Journal
Eur J Cancer
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2007-11-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kondo TToru

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Neoplastic Stem CellsMajor topic
Cell Communication
Cell Transformation, Neoplastic
Humans

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42043964MAP17 Enhances Chemoresistance and Tumorigenicity of Glioblastoma-Initiating Cells via the Canonical NF-кB Pathway.Cancer Sci2026https://conductscience.org/library/papers/42043964PubMed
41892329Neuronal Differentiation of GBM-Initiating Cells Combined with Elimination of Undifferentiated Cells Preserves Motor Function.Cells2026https://conductscience.org/library/papers/41892329PubMed
40217098Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system.Br J Cancer2025https://conductscience.org/library/papers/40217098PubMed
39734809A machine learning-assisted systematic review of preclinical glioma modeling: Is practice changing with the times?Neurooncol Adv2024https://conductscience.org/library/papers/39734809PubMed
39470407EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells.Neuro Oncol2025https://conductscience.org/library/papers/39470407PubMed
35986010Exosomal miR-155-5p derived from glioma stem-like cells promotes mesenchymal transition via targeting ACOT12.Cell Death Dis2022https://conductscience.org/library/papers/35986010PubMed
34370752Neural differentiation of glioblastoma cell lines via a herpes simplex virus thymidine kinase/ganciclovir system driven by a glial fibrillary acidic protein promoter.PLoS One2021https://conductscience.org/library/papers/34370752PubMed
32580319Exploiting Cancer's Tactics to Make Cancer a Manageable Chronic Disease.Cancers (Basel)2020https://conductscience.org/library/papers/32580319PubMed
31499527Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells.Neuro Oncol2020https://conductscience.org/library/papers/31499527PubMed
29991446Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.Cancer Lett2018https://conductscience.org/library/papers/29991446PubMed
27486877A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics.Oncotarget2016https://conductscience.org/library/papers/27486877PubMed
22973309Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche.J Oncol2012https://conductscience.org/library/papers/22973309PubMed
22584872Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.Neuro Oncol2012https://conductscience.org/library/papers/22584872PubMed
21453386Essential role of the Hedgehog signaling pathway in human glioma-initiating cells.Cancer Sci2011https://conductscience.org/library/papers/21453386PubMed
20549538Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.Cell Mol Life Sci2010https://conductscience.org/library/papers/20549538PubMed
19276344Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.Cancer Res2009https://conductscience.org/library/papers/19276344PubMed
18636315The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.Mol Cell Biochem2008https://conductscience.org/library/papers/18636315PubMed
17543444Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth.Cancer Lett2007https://conductscience.org/library/papers/17543444PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16632342

GET https://conductscience.org/api/papers/v1/16632342/authors